Semax/SelankAlso known as: Semax, Selank

Mechanism of Action

Semax acts primarily through modulation of neurotransmission, particularly influencing brain-derived neurotrophic factor (BDNF) pathways which support neuroprotection and cognitive enhancement. Selank exerts anxiolytic effects by regulating the central nervous system without sedation, potentially affecting neurotransmitters like serotonin and modulation of immune signaling peptides such as tuftsin. The combination provides synergistic effects by balancing stimulatory cognitive enhancement with anxiolytic and stress regulatory properties.

Reported Research Benefits

• Research into cognitive enhancement, memory and learning improvement, neuroprotection, stress and anxiety regulation, and neurological homeostasis models. Popular within nootropic and biohacking research communities.

Dosing Protocol & Reconstitution

Research Notes

Both peptides are under active preclinical and scientific investigation for their roles in enhancing focus, memory retention, reducing anxiety, and modulating stress responses. Semax exhibits neuroprotective antioxidant activity; Selank demonstrates anxiolytic effects without sedation. Combination is studied for balanced cognitive and emotional benefits. Half-life varies per peptide but generally short; repeated administration typical in protocols.

Research Summary

A combination of Semax and Selank providing synergistic cognitive enhancement with anxiolytic balance. Semax activates BDNF pathways and dopaminergic/serotonergic systems while Selank modulates enkephalins and exerts anxiolytic effects, making this a popular nootropic stack.

Side Effects & Safety

Mild nasal irritation with intranasal administration. No serious adverse events documented for the combination. Stimulatory effects from Semax may be moderated by Selank.

Stability & Storage

Refer to research notes

Molecular Data

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=Semax+Selank+nootropic+peptide+cognitive